Search research articles
Contact Us
Filters
Showing results (1-10 of 56) with videos related to
Page
of 6
Sort By:
Therapeutic Advances in Musculoskeletal Disease
|
October 5, 2017
Rituximab biosimilar in rheumatoid arthritis: an enhanced-evidence assessment to evaluate equivalence with the originator based on network meta-analysis
Marco Chiumente, Andrea Messori
Journal of Stroke
|
February 27, 2016
Differences in Effectiveness among Devices for Endovascular Thrombectomy in Patients with Acute Ischemic Stroke
Marco Chiumente, Sabrina Trippoli, Andrea Messori
Clinical Therapeutics
|
December 12, 2022
Chimeric Antigen Receptor T Cells in Large B-Cell Lymphoma: Analysis of Overall Survival Based on Reconstructed Patient-Level Data
Andrea Messori, Marco Chiumente, Daniele Mengato
Journal of Gastrointestinal Cancer
|
January 18, 2022
Adjuvant Nivolumab in Esophageal or Gastroesophageal Junction Cancer: the Improvement in Progression-Free Survival Is Small
Daniele Mengato, Marco Chiumente, Andrea Messori
Haematologica
|
September 23, 2017
Rituximab biosimilar evaluated by network meta-analysis
Marco Chiumente, Daniele Mengato, Andrea Messori
European Journal of Obstetrics, Gynecology, and Reproductive Biology
|
February 7, 2018
Ulipristal acetate for pre-operative management of uterine fibroids: Modeling outcomes and costs
Brigitta Badiani, Marco Chiumente, Andrea Messori
International Journal of Clinical Pharmacology and Therapeutics
|
December 22, 2018
Trastuzumab biosimilar in metastatic breast cancer: Evaluating equivalence with originator using network meta-analysis
Daniele Mengato, Marco Chiumente, Andrea Messori
Acta Haematologica
|
February 20, 2020
Tisagenlecleucel in Non-Hodgkin Lymphoma: The Restricted Mean Survival Time as a Tool for Estimating Progression-Free Life Expectancy Better than the Median
Marco Chiumente, Daniele Mengato, Andrea Messori
Journal of Cardiovascular Medicine (Hagerstown, Md.)
|
September 1, 2017
Promoting the use of Markovian simulation models to study outcomes of thrombectomy after acute ischemic stroke
Sabrina Trippoli, Marco Chiumente, Andrea Messori
JAMA Cardiology
|
March 2, 2022
Age-Adjusted Survival Extrapolations-Results May Differ From Those Generated by the Weibull Model
Andrea Messori, Daniele Mengato, Marco Chiumente
Page
of 6
Search research articles
Search
Showing results (1-10 of 56) with videos related to
Sort By:
Page
of 6
Therapeutic Advances in Musculoskeletal Disease
|
October 5, 2017
Rituximab biosimilar in rheumatoid arthritis: an enhanced-evidence assessment to evaluate equivalence with the originator based on network meta-analysis
Marco Chiumente, Andrea Messori
Journal of Stroke
|
February 27, 2016
Differences in Effectiveness among Devices for Endovascular Thrombectomy in Patients with Acute Ischemic Stroke
Marco Chiumente, Sabrina Trippoli, Andrea Messori
Clinical Therapeutics
|
December 12, 2022
Chimeric Antigen Receptor T Cells in Large B-Cell Lymphoma: Analysis of Overall Survival Based on Reconstructed Patient-Level Data
Andrea Messori, Marco Chiumente, Daniele Mengato
Journal of Gastrointestinal Cancer
|
January 18, 2022
Adjuvant Nivolumab in Esophageal or Gastroesophageal Junction Cancer: the Improvement in Progression-Free Survival Is Small
Daniele Mengato, Marco Chiumente, Andrea Messori
Haematologica
|
September 23, 2017
Rituximab biosimilar evaluated by network meta-analysis
Marco Chiumente, Daniele Mengato, Andrea Messori
European Journal of Obstetrics, Gynecology, and Reproductive Biology
|
February 7, 2018
Ulipristal acetate for pre-operative management of uterine fibroids: Modeling outcomes and costs
Brigitta Badiani, Marco Chiumente, Andrea Messori
International Journal of Clinical Pharmacology and Therapeutics
|
December 22, 2018
Trastuzumab biosimilar in metastatic breast cancer: Evaluating equivalence with originator using network meta-analysis
Daniele Mengato, Marco Chiumente, Andrea Messori
Acta Haematologica
|
February 20, 2020
Tisagenlecleucel in Non-Hodgkin Lymphoma: The Restricted Mean Survival Time as a Tool for Estimating Progression-Free Life Expectancy Better than the Median
Marco Chiumente, Daniele Mengato, Andrea Messori
Journal of Cardiovascular Medicine (Hagerstown, Md.)
|
September 1, 2017
Promoting the use of Markovian simulation models to study outcomes of thrombectomy after acute ischemic stroke
Sabrina Trippoli, Marco Chiumente, Andrea Messori
JAMA Cardiology
|
March 2, 2022
Age-Adjusted Survival Extrapolations-Results May Differ From Those Generated by the Weibull Model
Andrea Messori, Daniele Mengato, Marco Chiumente
Page
of 6